[
  {
    "ts": null,
    "headline": "ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down",
    "summary": "Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as gross and operating margins fall.",
    "url": "https://finnhub.io/api/news?id=ce0fd50793c01682a23d2679f124c4ba74db92f81dc421b550b8f826f1aa5974",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770296940,
      "headline": "ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down",
      "id": 138364668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as gross and operating margins fall.",
      "url": "https://finnhub.io/api/news?id=ce0fd50793c01682a23d2679f124c4ba74db92f81dc421b550b8f826f1aa5974"
    }
  },
  {
    "ts": null,
    "headline": "ResMed Deepens CPAP Lead As Wearables And Digital Tools Expand Reach",
    "summary": "ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role in sleep and respiratory care equipment. New drug therapies are expanding the potential patient pool that may still require CPAP support. Philips' ongoing CPAP recall continues to leave ResMed with a dominant share of the CPAP market. ResMed's digital ecosystem is playing a larger role in...",
    "url": "https://finnhub.io/api/news?id=e52e736e2d7d3188173ef01def638f87a5fb75d1ecb62c321160b0f973bf6a89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770271873,
      "headline": "ResMed Deepens CPAP Lead As Wearables And Digital Tools Expand Reach",
      "id": 138361587,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role in sleep and respiratory care equipment. New drug therapies are expanding the potential patient pool that may still require CPAP support. Philips' ongoing CPAP recall continues to leave ResMed with a dominant share of the CPAP market. ResMed's digital ecosystem is playing a larger role in...",
      "url": "https://finnhub.io/api/news?id=e52e736e2d7d3188173ef01def638f87a5fb75d1ecb62c321160b0f973bf6a89"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call",
    "summary": "ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its digital health software. CEO Michael Farrell highlighted double-digit growth in the U.S. mask segment—supported by the launch of new fabric mask products and expansion of direct-to-consumer initiatives. Management also pointed to operational efficiencies, particularly in supply chain and manufactu",
    "url": "https://finnhub.io/api/news?id=b1e15e46088259f127cec3af9b083e8cf72d557a04d6d5d91ad2069fae3ed72f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770270258,
      "headline": "The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call",
      "id": 138362820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its digital health software. CEO Michael Farrell highlighted double-digit growth in the U.S. mask segment—supported by the launch of new fabric mask products and expansion of direct-to-consumer initiatives. Management also pointed to operational efficiencies, particularly in supply chain and manufactu",
      "url": "https://finnhub.io/api/news?id=b1e15e46088259f127cec3af9b083e8cf72d557a04d6d5d91ad2069fae3ed72f"
    }
  }
]